SIMILAR PATTERNS OF AMINO ACIDS FOR 5ND2_B_TA1B601_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1aow ANNEXIN IV

(Bos taurus)
PF00191
(Annexin)
5 GLU A 276
ALA A  46
SER A  44
ARG A 122
ARG A  48
None
1.33A 5nd2B-1aowA:
undetectable
5nd2B-1aowA:
21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ddz CARBONIC ANHYDRASE

(Porphyridium
purpureum)
PF00484
(Pro_CA)
5 LEU A 481
ALA A 404
SER A 406
PRO A 142
LEU A 195
None
1.42A 5nd2B-1ddzA:
undetectable
5nd2B-1ddzA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1eth TRIACYLGLYCEROL
ACYL-HYDROLASE


(Sus scrofa)
PF00151
(Lipase)
PF01477
(PLAT)
5 ASP A 226
HIS A 224
ARG A 172
ARG A 191
LEU A 192
None
1.42A 5nd2B-1ethA:
4.3
5nd2B-1ethA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1eth TRIACYLGLYCEROL
ACYL-HYDROLASE


(Sus scrofa)
PF00151
(Lipase)
PF01477
(PLAT)
5 VAL A 322
HIS A 224
ARG A 172
ARG A 191
LEU A 192
None
1.38A 5nd2B-1ethA:
4.3
5nd2B-1ethA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1hpl LIPASE

(Equus caballus)
PF00151
(Lipase)
PF01477
(PLAT)
5 ASP A 225
HIS A 223
ARG A 171
ARG A 190
LEU A 191
None
1.40A 5nd2B-1hplA:
4.3
5nd2B-1hplA:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i0a DELTA CRYSTALLIN I

(Meleagris
gallopavo)
PF00206
(Lyase_1)
PF14698
(ASL_C2)
5 GLU A 258
LEU A 139
HIS A 176
ARG A 297
LEU A 293
None
1.38A 5nd2B-1i0aA:
undetectable
5nd2B-1i0aA:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nq6 XYS1

(Streptomyces
halstedii)
PF00331
(Glyco_hydro_10)
5 VAL A 124
ALA A 158
ARG A 101
ARG A 159
PRO A 197
None
1.37A 5nd2B-1nq6A:
2.9
5nd2B-1nq6A:
20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nrw HYPOTHETICAL
PROTEIN, HALOACID
DEHALOGENASE-LIKE
HYDROLASE


(Bacillus
subtilis)
PF08282
(Hydrolase_3)
5 VAL A 121
ASP A 124
GLU A 122
PHE A 104
ARG A  43
None
1.18A 5nd2B-1nrwA:
4.0
5nd2B-1nrwA:
19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o75 47 KDA MEMBRANE
ANTIGEN


(Treponema
pallidum)
PF14888
(PBP-Tp47_c)
PF14889
(PBP-Tp47_a)
5 VAL A 329
ASP A 328
ALA A 231
ARG A 259
LEU A 317
None
None
XE  A1415 ( 4.5A)
None
None
1.23A 5nd2B-1o75A:
undetectable
5nd2B-1o75A:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p33 PTERIDINE REDUCTASE
1


(Leishmania
tarentolae)
PF13561
(adh_short_C2)
5 VAL A 257
ASP A 259
GLU A 256
SER A 252
ARG A 250
None
1.40A 5nd2B-1p33A:
7.2
5nd2B-1p33A:
19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p9n MOLYBDOPTERIN-GUANIN
E DINUCLEOTIDE
BIOSYNTHESIS PROTEIN
B


(Escherichia
coli)
PF03205
(MobB)
5 ASP A 153
LEU A   5
ALA A 137
ARG A 117
LEU A  18
None
1.42A 5nd2B-1p9nA:
undetectable
5nd2B-1p9nA:
16.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1px5 2'-5'-OLIGOADENYLATE
SYNTHETASE 1


(Sus scrofa)
PF01909
(NTP_transf_2)
PF10421
(OAS1_C)
5 VAL A  78
ASP A  76
LEU A 172
ALA A 151
ARG A  94
None
0.96A 5nd2B-1px5A:
undetectable
5nd2B-1px5A:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r6b CLPA PROTEIN

(Escherichia
coli)
PF00004
(AAA)
PF02861
(Clp_N)
PF07724
(AAA_2)
PF10431
(ClpB_D2-small)
5 VAL X  27
LEU X  44
ALA X 120
SER X 118
ARG X  55
None
1.41A 5nd2B-1r6bX:
undetectable
5nd2B-1r6bX:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqy ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 2


(Streptomyces
coelicolor)
PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C)
5 VAL B 293
ASP B 292
LEU B 165
ALA B 345
SER B 348
None
1.25A 5nd2B-1tqyB:
undetectable
5nd2B-1tqyB:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1y79 PEPTIDYL-DIPEPTIDASE
DCP


(Escherichia
coli)
PF01432
(Peptidase_M3)
5 ASP 1 104
GLU 1 100
LEU 1  67
PHE 1  31
LEU 1  98
None
1.33A 5nd2B-1y791:
undetectable
5nd2B-1y791:
19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zjy R-SPECIFIC ALCOHOL
DEHYDROGENASE


(Lactobacillus
brevis)
PF13561
(adh_short_C2)
5 ASP A  67
GLU A  66
HIS A  61
ARG A 122
LEU A 123
None
1.42A 5nd2B-1zjyA:
7.0
5nd2B-1zjyA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy9 ALPHA-GALACTOSIDASE

(Thermotoga
maritima)
PF02065
(Melibiase)
5 ASP A 226
GLU A 224
ALA A 259
PHE A 328
ARG A 289
None
1.39A 5nd2B-1zy9A:
undetectable
5nd2B-1zy9A:
20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bec CALCINEURIN B
HOMOLOGOUS PROTEIN 2


(Homo sapiens)
PF13202
(EF-hand_5)
PF13499
(EF-hand_7)
5 ALA A  88
PHE A  23
ARG A  34
PRO A  92
LEU A 195
None
1.41A 5nd2B-2becA:
undetectable
5nd2B-2becA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fez PROBABLE REGULATORY
PROTEIN EMBR


(Mycobacterium
tuberculosis)
PF00486
(Trans_reg_C)
PF00498
(FHA)
PF03704
(BTAD)
5 VAL A 350
LEU A 303
PHE A 376
ARG A 309
LEU A 320
None
1.39A 5nd2B-2fezA:
undetectable
5nd2B-2fezA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ich PUTATIVE ATTH

(Nitrosomonas
europaea)
PF07143
(CrtC)
PF17186
(Lipocalin_9)
5 ASP A 313
HIS A 107
ALA A  96
SER A  98
ARG A 319
None
1.34A 5nd2B-2ichA:
undetectable
5nd2B-2ichA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o0r RV0858C
(N-SUCCINYLDIAMINOPI
MELATE
AMINOTRANSFERASE)


(Mycobacterium
tuberculosis)
PF00155
(Aminotran_1_2)
5 VAL A 134
GLU A 111
LEU A 147
ALA A 155
LEU A 193
None
1.25A 5nd2B-2o0rA:
undetectable
5nd2B-2o0rA:
22.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o4u DIMERIC DIHYDRODIOL
DEHYDROGENASE


(Macaca
fascicularis)
PF01408
(GFO_IDH_MocA)
5 VAL X1106
GLU X1122
ALA X1315
PRO X1098
LEU X1175
None
1.24A 5nd2B-2o4uX:
4.7
5nd2B-2o4uX:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o6i HD DOMAIN PROTEIN

(Enterococcus
faecalis)
PF01966
(HD)
5 GLU A  60
LEU A 259
SER A  53
PHE A 323
ARG A 326
None
1.34A 5nd2B-2o6iA:
undetectable
5nd2B-2o6iA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pun METHYLTHIORIBOSE
KINASE


(Bacillus
subtilis)
PF01636
(APH)
5 VAL A 263
ASP A 262
ALA A 330
ARG A 340
PRO A 258
None
None
None
SR1  A 998 (-2.9A)
None
1.39A 5nd2B-2punA:
undetectable
5nd2B-2punA:
24.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qf7 PYRUVATE CARBOXYLASE
PROTEIN


(Rhizobium etli)
PF00289
(Biotin_carb_N)
PF00364
(Biotin_lipoyl)
PF00682
(HMGL-like)
PF02436
(PYC_OADA)
PF02785
(Biotin_carb_C)
PF02786
(CPSase_L_D2)
5 VAL A  30
ASP A  47
GLU A  48
ALA A  83
SER A  81
None
1.43A 5nd2B-2qf7A:
undetectable
5nd2B-2qf7A:
17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rfo NUCLEOPORIN NIC96

(Saccharomyces
cerevisiae)
PF04097
(Nic96)
5 VAL A 219
GLU A 555
HIS A 505
ALA A 216
PHE A 212
None
1.35A 5nd2B-2rfoA:
undetectable
5nd2B-2rfoA:
19.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vwq GLUCOSE
DEHYDROGENASE


(Haloferax
mediterranei)
PF08240
(ADH_N)
PF16912
(Glu_dehyd_C)
5 VAL A 299
LEU A 192
ALA A 162
SER A 165
LEU A 263
None
1.34A 5nd2B-2vwqA:
undetectable
5nd2B-2vwqA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yxe PROTEIN-L-ISOASPARTA
TE
O-METHYLTRANSFERASE


(Methanocaldococcus
jannaschii)
PF01135
(PCMT)
5 VAL A 130
ASP A 128
ALA A  93
PHE A  37
ARG A 120
None
1.38A 5nd2B-2yxeA:
undetectable
5nd2B-2yxeA:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0f PUTATIVE
PHOSPHOGLUCOMUTASE


(Thermus
thermophilus)
PF00408
(PGM_PMM_IV)
PF02878
(PGM_PMM_I)
PF02879
(PGM_PMM_II)
PF02880
(PGM_PMM_III)
5 GLU A 370
HIS A 292
ALA A 375
PHE A 367
LEU A 335
None
1.21A 5nd2B-2z0fA:
undetectable
5nd2B-2z0fA:
21.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zc0 ALANINE GLYOXYLATE
TRANSAMINASE


(Thermococcus
litoralis)
PF00155
(Aminotran_1_2)
5 VAL A 241
GLU A 213
LEU A 291
PHE A 219
PRO A 229
None
1.32A 5nd2B-2zc0A:
undetectable
5nd2B-2zc0A:
24.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a1z HEMOLYMPH JUVENILE
HORMONE BINDING
PROTEIN


(Bombyx mori)
PF06585
(JHBP)
5 VAL A  50
ASP A  49
LEU A 161
ALA A 192
LEU A  65
None
None
None
MPD  A 232 ( 4.3A)
None
1.04A 5nd2B-3a1zA:
undetectable
5nd2B-3a1zA:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aoe GLUTAMATE
DEHYDROGENASE


(Thermus
thermophilus)
no annotation 5 GLU E 317
LEU E 107
ARG E 397
PRO E 340
LEU E 343
None
1.23A 5nd2B-3aoeE:
undetectable
5nd2B-3aoeE:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fdu PUTATIVE ENOYL-COA
HYDRATASE/ISOMERASE


(Acinetobacter
baumannii)
PF00378
(ECH_1)
5 VAL A  56
LEU A  13
ALA A  50
ARG A  62
LEU A 108
None
0.97A 5nd2B-3fduA:
undetectable
5nd2B-3fduA:
20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h4x PHOSPHATIDYLINOSITOL
-SPECIFIC
PHOSPHOLIPASE C1


(Streptomyces
antibioticus)
PF16670
(PI-PLC-C1)
5 VAL A  36
ALA A  51
SER A  54
PHE A  48
LEU A 126
None
1.32A 5nd2B-3h4xA:
undetectable
5nd2B-3h4xA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3it4 ARGININE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
ARGJ BETA CHAIN


(Mycobacterium
tuberculosis)
PF01960
(ArgJ)
5 VAL B 364
GLU B 363
LEU B 327
ALA B 361
ARG B 325
None
None
None
None
ACT  B 601 (-4.0A)
1.29A 5nd2B-3it4B:
undetectable
5nd2B-3it4B:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iwj PUTATIVE
AMINOALDEHYDE
DEHYDROGENASE


(Pisum sativum)
PF00171
(Aldedh)
5 VAL A 155
ASP A 232
LEU A 206
ALA A 175
PRO A 151
None
1.25A 5nd2B-3iwjA:
undetectable
5nd2B-3iwjA:
20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iwk AMINOALDEHYDE
DEHYDROGENASE


(Pisum sativum)
PF00171
(Aldedh)
5 VAL A 155
ASP A 232
LEU A 206
ALA A 175
PRO A 151
None
1.17A 5nd2B-3iwkA:
2.5
5nd2B-3iwkA:
22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ju8 SUCCINYLGLUTAMIC
SEMIALDEHYDE
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF00171
(Aldedh)
5 VAL A 140
ASP A 216
LEU A 191
ALA A 160
PRO A 136
None
1.13A 5nd2B-3ju8A:
undetectable
5nd2B-3ju8A:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kio RIBONUCLEASE H2
SUBUNIT A


(Mus musculus)
PF01351
(RNase_HII)
5 ASP A 204
GLU A 198
LEU A 246
ARG A 222
LEU A  42
None
1.09A 5nd2B-3kioA:
undetectable
5nd2B-3kioA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kop UNCHARACTERIZED
PROTEIN


(Arthrobacter
sp. FB24)
PF12903
(DUF3830)
5 LEU A  88
ALA A 111
PHE A  81
PRO A  73
LEU A 120
None
1.17A 5nd2B-3kopA:
undetectable
5nd2B-3kopA:
19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lm3 UNCHARACTERIZED
PROTEIN


(Parabacteroides
distasonis)
PF12979
(DUF3863)
PF12980
(DUF3864)
5 GLU A 424
LEU A  70
ALA A 143
SER A 181
PRO A 425
None
1.38A 5nd2B-3lm3A:
undetectable
5nd2B-3lm3A:
20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n23 SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1


(Sus scrofa)
PF00122
(E1-E2_ATPase)
PF00689
(Cation_ATPase_C)
PF00690
(Cation_ATPase_N)
PF13246
(Cation_ATPase)
5 VAL A 734
ASP A 733
ALA A 264
SER A 268
PRO A  76
None
1.26A 5nd2B-3n23A:
2.3
5nd2B-3n23A:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3olz GLUTAMATE RECEPTOR,
IONOTROPIC KAINATE 3


(Rattus
norvegicus)
PF01094
(ANF_receptor)
5 VAL A  75
LEU A 295
ALA A  77
ARG A  30
LEU A  48
None
1.28A 5nd2B-3olzA:
4.4
5nd2B-3olzA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3op0 SIGNAL TRANSDUCTION
PROTEIN CBL-C


(Homo sapiens)
PF02262
(Cbl_N)
PF02761
(Cbl_N2)
PF02762
(Cbl_N3)
5 ASP A 245
GLU A 246
LEU A  48
ARG A  45
LEU A 121
None
1.35A 5nd2B-3op0A:
undetectable
5nd2B-3op0A:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3phf ENVELOPE
GLYCOPROTEIN H


(Human
gammaherpesvirus
4)
no annotation 5 VAL A 462
GLU A 458
SER A 476
ARG A 488
LEU A 486
None
1.28A 5nd2B-3phfA:
undetectable
5nd2B-3phfA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sju KETO REDUCTASE

(Streptomyces
griseoruber)
PF00106
(adh_short)
5 ASP A  66
GLU A  67
ALA A  71
PHE A   8
ARG A 125
None
1.29A 5nd2B-3sjuA:
6.6
5nd2B-3sjuA:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uai H/ACA
RIBONUCLEOPROTEIN
COMPLEX SUBUNIT 4


(Saccharomyces
cerevisiae)
PF01472
(PUA)
PF01509
(TruB_N)
PF08068
(DKCLD)
PF16198
(TruB_C_2)
5 VAL A 336
LEU A  25
ALA A 314
ARG A 111
LEU A 112
None
1.42A 5nd2B-3uaiA:
undetectable
5nd2B-3uaiA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uan HEPARAN SULFATE
GLUCOSAMINE
3-O-SULFOTRANSFERASE
1


(Mus musculus)
PF00685
(Sulfotransfer_1)
5 VAL A 235
GLU A 236
PHE A 250
ARG A  72
LEU A  80
None
None
None
BDP  A   2 (-3.6A)
None
1.19A 5nd2B-3uanA:
2.4
5nd2B-3uanA:
21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3umv DEOXYRIBODIPYRIMIDIN
E PHOTO-LYASE


(Oryza sativa)
PF00875
(DNA_photolyase)
5 VAL A 313
ASP A 314
LEU A 288
ALA A 302
LEU A 200
None
None
FAD  A 801 (-4.4A)
None
None
1.41A 5nd2B-3umvA:
undetectable
5nd2B-3umvA:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a0m BETAINE ALDEHYDE
DEHYDROGENASE,
CHLOROPLASTIC


(Spinacia
oleracea)
PF00171
(Aldedh)
5 VAL A 152
ASP A 229
LEU A 203
ALA A 172
PRO A 148
None
1.16A 5nd2B-4a0mA:
2.4
5nd2B-4a0mA:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b0n POLYKETIDE SYNTHASE
III


(Ectocarpus
siliculosus)
PF00195
(Chal_sti_synt_N)
PF02797
(Chal_sti_synt_C)
5 VAL A 160
GLU A 222
ALA A 196
SER A 367
LEU A 284
None
None
None
None
ACD  A1416 (-4.3A)
1.39A 5nd2B-4b0nA:
undetectable
5nd2B-4b0nA:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cca SYNTAXIN-BINDING
PROTEIN 2


(Homo sapiens)
PF00995
(Sec1)
5 ASP A 255
GLU A 246
ALA A 543
SER A 545
LEU A 243
None
1.17A 5nd2B-4ccaA:
undetectable
5nd2B-4ccaA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cca SYNTAXIN-BINDING
PROTEIN 2


(Homo sapiens)
PF00995
(Sec1)
5 VAL A 478
GLU A 546
ALA A 237
ARG A 190
ARG A 235
None
1.38A 5nd2B-4ccaA:
undetectable
5nd2B-4ccaA:
22.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dwe UNCHARACTERIZED
PROTEIN


(Bacteroides
ovatus)
PF15421
(Polysacc_deac_3)
5 GLU A 368
LEU A 215
ALA A 211
SER A 209
ARG A 245
None
1.42A 5nd2B-4dweA:
undetectable
5nd2B-4dweA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e84 D-BETA-D-HEPTOSE
7-PHOSPHATE KINASE


(Burkholderia
cenocepacia)
PF00294
(PfkB)
5 VAL A 301
ASP A 264
LEU A  70
ALA A 297
ARG A  65
None
K  A 503 (-4.8A)
None
ANP  A 501 (-3.7A)
None
1.34A 5nd2B-4e84A:
5.7
5nd2B-4e84A:
19.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fmc RORF2

(Escherichia
coli)
PF06872
(EspG)
5 VAL A 340
LEU A 234
ALA A 290
SER A 342
PHE A 291
None
1.25A 5nd2B-4fmcA:
undetectable
5nd2B-4fmcA:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i8p AMINOALDEHYDE
DEHYDROGENASE 1


(Zea mays)
PF00171
(Aldedh)
5 VAL A 157
ASP A 234
LEU A 208
ALA A 177
PRO A 153
None
1.13A 5nd2B-4i8pA:
undetectable
5nd2B-4i8pA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i8q PUTATIVE BETAINE
ALDEHYDE
DEHYROGENASE


(Solanum
lycopersicum)
PF00171
(Aldedh)
5 VAL A 155
ASP A 232
LEU A 206
ALA A 175
PRO A 151
None
1.19A 5nd2B-4i8qA:
2.2
5nd2B-4i8qA:
22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lde LYSOZYME, BETA-2
ADRENERGIC RECEPTOR


(Escherichia
virus T4;
Homo sapiens)
PF00001
(7tm_1)
PF00959
(Phage_lysozyme)
5 VAL A 968
GLU A 973
ALA A 939
ARG A 945
LEU A 944
None
1.26A 5nd2B-4ldeA:
undetectable
5nd2B-4ldeA:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m0x CHLOROMUCONATE
CYCLOISOMERASE


(Rhodococcus
opacus)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ASP A 334
GLU A 335
SER A 303
ARG A 366
LEU A 360
None
1.34A 5nd2B-4m0xA:
undetectable
5nd2B-4m0xA:
21.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ofx CYSTATHIONINE
BETA-SYNTHASE


(Coxiella
burnetii)
PF00291
(PALP)
5 VAL A 176
ALA A 276
ARG A 288
ARG A 282
LEU A 283
None
1.36A 5nd2B-4ofxA:
undetectable
5nd2B-4ofxA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ogc HNH ENDONUCLEASE
DOMAIN PROTEIN


(Actinomyces
naeslundii)
PF01844
(HNH)
5 ASP A 876
GLU A 875
ALA A 873
ARG A 837
LEU A 838
None
1.28A 5nd2B-4ogcA:
undetectable
5nd2B-4ogcA:
16.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pz2 ZMALDH

(Zea mays)
PF00171
(Aldedh)
5 ASP A 494
GLU A 495
ALA A 195
SER A 143
LEU A 500
None
1.37A 5nd2B-4pz2A:
undetectable
5nd2B-4pz2A:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rjw PORIN O

(Pseudomonas
aeruginosa)
PF07396
(Porin_O_P)
5 VAL A 407
ASP A  38
ALA A 385
PHE A 338
ARG A 133
None
1.32A 5nd2B-4rjwA:
undetectable
5nd2B-4rjwA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yx7 OXYGEN-REGULATED
INVASION PROTEIN
ORGB,ENDOLYSIN


(Escherichia
virus T4;
Salmonella
enterica)
PF00959
(Phage_lysozyme)
5 VAL C 136
GLU C 141
ALA C 107
ARG C 113
LEU C 112
None
1.19A 5nd2B-4yx7C:
undetectable
5nd2B-4yx7C:
18.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ztx COBALAMIN-INDEPENDEN
T METHIONINE
SYNTHASE


(Neurospora
crassa)
PF01717
(Meth_synt_2)
PF08267
(Meth_synt_1)
5 VAL A 161
GLU A 210
HIS A  68
SER A 165
PHE A 117
None
1.39A 5nd2B-4ztxA:
undetectable
5nd2B-4ztxA:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5aa4 MEMBRANE-BOUND LYTIC
MUREIN
TRANSGLYCOSYLASE F


(Pseudomonas
aeruginosa)
PF00497
(SBP_bac_3)
PF01464
(SLT)
5 LEU B  82
SER B 123
PHE B  74
ARG B  46
LEU B 241
None
1.09A 5nd2B-5aa4B:
undetectable
5nd2B-5aa4B:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e72 N2,
N2-DIMETHYLGUANOSINE
TRNA
METHYLTRANSFERASE


(Thermococcus
kodakarensis)
PF01170
(UPF0020)
PF02926
(THUMP)
5 ASP A  33
LEU A 107
ALA A  65
ARG A 128
LEU A  61
None
1.37A 5nd2B-5e72A:
2.2
5nd2B-5e72A:
23.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ed7 TEGUMENT PROTEIN
UL21


(Human
alphaherpesvirus
1)
PF03252
(Herpes_UL21)
5 VAL A 495
ASP A 494
ALA A 403
PHE A 462
LEU A 488
None
1.15A 5nd2B-5ed7A:
undetectable
5nd2B-5ed7A:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5evy SALICYLATE
HYDROXYLASE


(Pseudomonas
putida)
PF01494
(FAD_binding_3)
5 VAL X 141
GLU X 136
LEU X  24
ALA X 156
LEU X 353
None
1.39A 5nd2B-5evyX:
undetectable
5nd2B-5evyX:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fg0 E3 UBIQUITIN-PROTEIN
LIGASE LISTERIN


(Saccharomyces
cerevisiae)
no annotation 5 GLU A  46
LEU A 121
SER A  44
PHE A  87
LEU A  69
None
1.37A 5nd2B-5fg0A:
undetectable
5nd2B-5fg0A:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h5x PUTATIVE
OXIDOREDUCTASE


(Streptomyces
coelicolor)
PF13561
(adh_short_C2)
5 VAL A 234
GLU A 233
LEU A 159
ARG A 227
LEU A 228
None
None
IPA  A 302 ( 4.4A)
None
None
1.42A 5nd2B-5h5xA:
6.4
5nd2B-5h5xA:
22.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h8y SULFITE REDUCTASE
[FERREDOXIN],
CHLOROPLASTIC


(Zea mays)
PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr)
5 VAL A 113
LEU A 166
ARG A 509
PRO A 498
LEU A 499
None
None
None
None
SRM  A 702 ( 4.7A)
1.26A 5nd2B-5h8yA:
undetectable
5nd2B-5h8yA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hj7 GLUTAMATE RACEMASE

(Mycobacterium
tuberculosis)
PF01177
(Asp_Glu_race)
5 LEU A 250
HIS A 187
SER A  77
ARG A 154
PRO A  46
None
DGL  A 301 ( 4.4A)
DGL  A 301 (-2.7A)
None
None
1.20A 5nd2B-5hj7A:
2.2
5nd2B-5hj7A:
19.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lmp TRANSLATION
INITIATION FACTOR
IF-3


(Thermus
thermophilus)
PF00707
(IF3_C)
PF05198
(IF3_N)
5 GLU X  96
PHE X  90
ARG X 108
ARG X 139
LEU X 103
None
None
U  A 793 ( 3.6A)
None
None
1.27A 5nd2B-5lmpX:
undetectable
5nd2B-5lmpX:
16.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lq3 CMEB

(Campylobacter
jejuni)
PF00873
(ACR_tran)
5 VAL A 407
ASP A 409
ALA A 403
SER A 480
LEU A 928
None
1.40A 5nd2B-5lq3A:
undetectable
5nd2B-5lq3A:
19.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mjs TUBULIN BETA CHAIN

(Schizosaccharomyces
pombe)
no annotation 7 ASP A  26
GLU A  27
LEU A 215
HIS A 227
ALA A 231
PRO A 357
LEU A 360
None
1.18A 5nd2B-5mjsA:
55.4
5nd2B-5mjsA:
59.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5mjs TUBULIN BETA CHAIN

(Schizosaccharomyces
pombe)
no annotation 7 ASP A  26
GLU A  27
LEU A 215
HIS A 227
ARG A 317
PRO A 357
LEU A 360
None
1.13A 5nd2B-5mjsA:
55.4
5nd2B-5mjsA:
59.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mkk MULTIDRUG RESISTANCE
ABC TRANSPORTER
ATP-BINDING AND
PERMEASE PROTEIN


(Thermus
thermophilus)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
5 ALA B  30
SER B  34
ARG B  23
ARG B 142
LEU B 138
None
1.43A 5nd2B-5mkkB:
undetectable
5nd2B-5mkkB:
21.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 7 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
PHE B 272
ARG B 320
None
1.22A 5nd2B-5n5nB:
56.0
5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 8 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
PHE B 272
ARG B 320
None
1.19A 5nd2B-5n5nB:
56.0
5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 8 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
ARG B 320
PRO B 360
LEU B 371
None
0.82A 5nd2B-5n5nB:
56.0
5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5n5n TUBULIN BETA CHAIN

(Homo sapiens)
no annotation 9 VAL B  23
GLU B  27
LEU B 217
HIS B 229
ALA B 233
PHE B 272
ARG B 320
PRO B 360
LEU B 371
None
0.89A 5nd2B-5n5nB:
56.0
5nd2B-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nth PUTATIVE
AMINOPEPTIDASE


(Leishmania
major)
PF00883
(Peptidase_M17)
5 VAL A 152
GLU A 149
LEU A  62
ALA A 144
SER A 148
None
1.36A 5nd2B-5nthA:
undetectable
5nd2B-5nthA:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nws SAACMM

(Streptomyces
antibioticus)
no annotation 5 GLU A 414
HIS A 286
ALA A 282
PRO A 413
LEU A 408
PG4  A 503 ( 4.6A)
None
None
None
None
1.29A 5nd2B-5nwsA:
undetectable
5nd2B-5nwsA:
14.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u2g PENICILLIN-BINDING
PROTEIN 1A


(Haemophilus
influenzae)
PF00905
(Transpeptidase)
PF00912
(Transgly)
PF17092
(PCB_OB)
5 GLU A  86
LEU A 191
ARG A 222
PRO A 203
LEU A 202
None
1.40A 5nd2B-5u2gA:
undetectable
5nd2B-5u2gA:
18.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v9x ATP-DEPENDENT DNA
HELICASE


(Mycolicibacterium
smegmatis)
no annotation 5 VAL A 239
LEU A 648
ALA A 419
PHE A 615
ARG A 624
None
0.98A 5nd2B-5v9xA:
undetectable
5nd2B-5v9xA:
11.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5w1j THIOREDOXIN
GLUTATHIONE
REDUCTASE


(Echinococcus
granulosus)
no annotation 5 VAL A 416
ASP A 417
ALA A 429
SER A 434
LEU A 451
None
1.27A 5nd2B-5w1jA:
undetectable
5nd2B-5w1jA:
20.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5w3j TUBULIN BETA CHAIN

(Saccharomyces
cerevisiae)
PF00091
(Tubulin)
PF03953
(Tubulin_C)
7 VAL B  23
ASP B  26
GLU B  27
LEU B 215
ARG B 318
PRO B 358
LEU B 361
TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
None
None
None
TA1  B 502 (-3.7A)
0.82A 5nd2B-5w3jB:
55.7
5nd2B-5w3jB:
75.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5w3j TUBULIN BETA CHAIN

(Saccharomyces
cerevisiae)
PF00091
(Tubulin)
PF03953
(Tubulin_C)
7 VAL B  23
ASP B  26
GLU B  27
SER B 234
ARG B 318
PRO B 358
LEU B 361
TA1  B 502 (-3.9A)
TA1  B 502 (-4.1A)
TA1  B 502 (-3.6A)
TA1  B 502 ( 4.9A)
None
None
TA1  B 502 (-3.7A)
0.94A 5nd2B-5w3jB:
55.7
5nd2B-5w3jB:
75.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wp4 PHOSPHOETHANOLAMINE
N-METHYLTRANSFERASE
1


(Arabidopsis
thaliana)
no annotation 5 ASP A  38
GLU A  41
LEU A  78
PHE A 124
ARG A 157
None
1.04A 5nd2B-5wp4A:
undetectable
5nd2B-5wp4A:
21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x7u TREHALOSE SYNTHASE

(Thermobaculum
terrenum)
no annotation 5 PHE A 465
ARG A 273
ARG A 478
PRO A 367
LEU A 366
None
1.28A 5nd2B-5x7uA:
undetectable
5nd2B-5x7uA:
12.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xom GLYCOSAMINOGLYCAN
XYLOSYLKINASE


(Hydra vulgaris)
no annotation 5 ASP A 123
HIS A  70
ALA A  98
SER A 101
ARG A 178
None
1.25A 5nd2B-5xomA:
undetectable
5nd2B-5xomA:
11.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3r DNA-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
X-RAY REPAIR
CROSS-COMPLEMENTING
PROTEIN 6


(Homo sapiens)
PF00454
(PI3_PI4_kinase)
PF02259
(FAT)
PF02260
(FATC)
PF02735
(Ku)
PF03730
(Ku_C)
PF03731
(Ku_N)
PF08163
(NUC194)
5 LEU C 230
ALA C 199
SER A 314
PHE C 200
LEU C 162
None
1.08A 5nd2B-5y3rC:
undetectable
5nd2B-5y3rC:
7.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ykb TREHALOSE SYNTHASE

(Deinococcus
radiodurans)
no annotation 5 PHE A 474
ARG A 282
ARG A 487
PRO A 376
LEU A 375
None
1.34A 5nd2B-5ykbA:
undetectable
5nd2B-5ykbA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ay1 NUCLEOSIDE
DIPHOSPHATE KINASE


(Helicobacter
pylori)
PF00334
(NDK)
5 VAL A  33
LEU A  39
ALA A  35
PHE A 132
LEU A   6
None
1.41A 5nd2B-6ay1A:
undetectable
5nd2B-6ay1A:
16.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cr0 (S)-6-HYDROXYNICOTIN
E OXIDASE


(Shinella sp.
HZN7)
no annotation 5 GLU A  71
ALA A 216
ARG A  39
ARG A  22
LEU A  18
None
1.23A 5nd2B-6cr0A:
undetectable
5nd2B-6cr0A:
9.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fd2 PUTATIVE APRAMYCIN
BIOSYNTHETIC
OXIDOREDUCTASE 4


(Streptoalloteichus
tenebrarius)
no annotation 5 VAL B 342
GLU B 373
LEU B 322
ARG B 335
LEU B 367
None
1.30A 5nd2B-6fd2B:
undetectable
5nd2B-6fd2B:
11.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fsh OXYB PROTEIN

(Actinoplanes
teichomyceticus)
no annotation 5 LEU A  88
SER A 212
PHE A 107
ARG A 111
LEU A 155
HEM  A 401 (-3.3A)
None
None
None
HEM  A 401 ( 4.8A)
1.39A 5nd2B-6fshA:
undetectable
5nd2B-6fshA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ft5 -

(-)
no annotation 5 VAL A  21
GLU A  22
ALA A  51
ARG A  37
LEU A  28
None
None
None
GOL  A 502 (-3.1A)
None
1.38A 5nd2B-6ft5A:
undetectable
5nd2B-6ft5A:
undetectable